Technology
Health
Medical

Heska

$74.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.11 (0.14%) As of 3:20 PM EDT today
+$0.11 (0.14%) Today

Why Robinhood?

You can buy or sell Heska and other stocks, options, ETFs, and crypto commission-free!

About HSKA

Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through two segments: Core Companion Animal Health and Other Vaccines & Pharmaceuticals. Read More The Core Companion Animal Health segment includes point of care diagnostic laboratory instruments and supplies, imaging instruments, software, and services as well as single use diagnostic and other tests, pharmaceuticals, and vaccines. The Other Vaccines & Pharmaceuticals segment focuses on private label vaccine and pharmaceutical production, primarily for cattle, but also for equine, porcine, avian, feline, and canine. Heska was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.

Employees
347
Headquarters
Loveland, Colorado
Founded
1988
Market Cap
576.12M
Price-Earnings Ratio
266.46
Dividend Yield
0.00
Average Volume
93.29K
High Today
$74.81
Low Today
$73.16
Open Price
$74.00
Volume
27.35K
52 Week High
$114.50
52 Week Low
$68.74

Collections

Technology
Health
Medical
Software Service
Pharmaceutical
US
North America

HSKA News

ReutersAug 9

Edited Transcript of HSKA earnings conference call or presentation 6-Aug-19 3:00pm GMT

3

HSKA Earnings

-$0.09
$0.19
$0.48
$0.76
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.09 per share
Actual
-$0.07 per share

More HSKA News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.